" class="no-js "lang="en-US"> AML Archives - Medtech Alert
Thursday, February 09, 2023

Sort by:


Top Post

CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM

CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]

Actinium Signs Cooperative Research and Development Agreement with National Cancer Institute

Actinium Pharmaceuticals, a leader in the development of targeted radiotherapies, have announced that it has […]

STORM Therapeutics Presents STC-15 Preclinical Data Supporting Treatment of Patients with AML

STORM Therapeutics, the clinical-stage biotechnology company discovering and developing novel small molecule therapies targeting RNA […]

Priothera Announces First Patients Enrolled in Pivotal Global Study for Patients with Acute Myeloid Leukemia

Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator compound […]

  1. ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics Read more
  2. Superior HealthPlan and eFamilyCare Expand Partnership to Support Medicaid Members and Caregivers in Texas Read more
  3. Garuda Therapeutics Secures $62 Million Series B Financing to Advance Off-the-Shelf Blood Stem Cell Technology Platform Read more
  4. FSD Pharma Receives Regulatory Clearance for Its Proposed Phase-1 Clinical Trial of Lucid-21-302 (Lucid-MS), First-in-Class Multiple Sclerosis Drug Candidate Read more
  5. $25 Million Gift to Penn Medicine and Children’s Hospital of Philadelphia Establishes Center for Epilepsy and Neurodevelopmental Disorders Read more